

Korsana Biosciences Inc (KRSA)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy KRSA Stock
Start investing in KRSA
About Korsana Biosciences Inc (KRSA)
| Market cap | $1.42B |
| Yesterday's volume | 159.95K |
| Revenue (TTM) | $1.03M |
| Avg. daily volume | 83.57K |
| EBITDA (TTM) | -$54.06M |
| Open | $31.35 |
| Price / earnings ratio | -2.38x |
| Yesterday's range | $29.99 - $31.52 |
| Debt / equity | 0x |
| 52 week range | $7.19 - $59.36 |
| 5 year debt / equity | — |
| Beta (LTM) | 0.81x |
| Interest coverage | — |
| Dividend & yield | $0.00 (0.00%) |
| Current ratio | 10.42x |
| Ex-dividend date | |
| Next earnings | |
| Dividend payable date |
KRSA Stock Rating
KRSA Stock News


Frequently Asked Questions (FAQ)
How to buy KRSA stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in KRSA stock
Navigate to the Explore page. Then, type KRSA into the search bar. When you see KRSA stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased KRSA stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.
Korsana Biosciences Inc Stock Earnings
The value each KRSA share was expected to gain vs. the value that each KRSA share actually gained.
KRSA (KRSA) reported Q3 2026 earnings per share (EPS) of -$3.19, missing estimates of -$0.70 by 355.71%. In the same quarter last year, KRSA's earnings per share (EPS) was $0. KRSA is expected to release next earnings on , with an earnings per share (EPS) estimate of -$1.07.
Buy KRSA Stock
Start investing in KRSA
Order type
Buy in
Order amount
Est. shares
0 shares